Spleen stiffness scan could spare liver patients painful biopsies

NCT ID NCT07440511

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether measuring spleen stiffness with a special ultrasound probe can detect advanced liver scarring in people with metabolic fatty liver disease (MASLD). Researchers will follow 500 adults for up to several years to see if the test predicts serious liver problems like cirrhosis or liver cancer. The goal is to replace invasive liver biopsies with a quick, painless scan.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
spleen stiffness measurement (non-invasive ultrasound-based test)
What this could lead to
If successful, this could provide a simple, needle-free way to detect advanced liver scarring early and predict complications in people with fatty liver disease.
What could go wrong
This is an observational study, not a treatment trial. The test may not prove accurate enough to replace current methods, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fondazione Policlinico Universitario A. Gemelli IRCCS

    RECRUITING

    Rome, 00168, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.